Follow
Andrew S. Huhn
Andrew S. Huhn
Johns Hopkins School of Medicine
Verified email at jhu.edu
Title
Cited by
Cited by
Year
Why aren't physicians prescribing more buprenorphine?
AS Huhn, KE Dunn
Journal of Substance Abuse Treatment 78, 1-7, 2017
2942017
A hidden aspect of the US opioid crisis: rise in first-time treatment admissions for older adults with opioid use disorder
AS Huhn, EC Strain, DA Tompkins, KE Dunn
Drug and alcohol dependence 193, 142-147, 2018
1182018
Sex‐Based Differences in Treatment Outcomes for Persons With Opioid Use Disorder
AS Huhn, MS Berry, KE Dunn
The American journal on addictions 28 (4), 246-261, 2019
832019
Method for successfully inducting individuals who use illicit fentanyl onto buprenorphine/naloxone
D Antoine, AS Huhn, EC Strain, G Turner, J Jardot, AS Hammond, ...
The American Journal on Addictions 30 (1), 83-87, 2021
692021
Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States
AS Huhn, JG Hobelmann, JC Strickland, GA Oyler, CL Bergeria, ...
JAMA Network Open 3 (2), e1920843-e1920843, 2020
692020
Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl
NB Varshneya, AP Thakrar, JG Hobelmann, KE Dunn, AS Huhn
Journal of addiction medicine 16 (4), e265-e268, 2008
662008
Protracted renal clearance of fentanyl in persons with opioid use disorder
AS Huhn, JG Hobelmann, GA Oyler, EC Strain
Drug and alcohol dependence 214, 108147, 2020
632020
Daily sleep quality affects drug craving, partially through indirect associations with positive affect, in patients in treatment for nonmedical use of prescription drugs
DM Lydon-Staley, HH Cleveland, AS Huhn, MJ Cleveland, J Harris, ...
Addictive behaviors 65, 275-282, 2017
632017
Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence
AS Huhn, RE Meyer, JD Harris, H Ayaz, E Deneke, DM Stankoski, ...
Brain research bulletin 123, 102-109, 2016
622016
Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence
AS Huhn, J Harris, HH Cleveland, DM Lydon, D Stankoski, MJ Cleveland, ...
Brain research bulletin 123, 94-101, 2016
542016
Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence
KE Dunn, AS Huhn, CL Bergeria, CD Gipson, EM Weerts
Journal of Pharmacology and Experimental Therapeutics 371 (2), 422-452, 2019
482019
Craving and opioid use disorder: A scoping review
BA Kleykamp, M De Santis, RH Dworkin, AS Huhn, KM Kampman, ...
Drug and alcohol dependence 205, 107639, 2019
462019
Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients
AS Huhn, MM Sweeney, RK Brooner, MS Kidorf, DA Tompkins, H Ayaz, ...
Neuropsychopharmacology 44 (4), 826-833, 2019
462019
The relationship between treatment accessibility and preference amongst out-of-treatment individuals who engage in non-medical prescription opioid use
AS Huhn, DA Tompkins, KE Dunn
Drug and alcohol dependence 180, 279-285, 2017
462017
Challenges for Women Entering Treatment for Opioid Use Disorder
AS Huhn, KE Dunn
Current Psychiatry Reports 22 (12), 1-10, 2020
452020
Systematic review of sex-based differences in opioid-based effects
AS Huhn, MS Berry, KE Dunn
International Review of Psychiatry 30 (5), 107-116, 2018
422018
A systematic review of laboratory evidence for the abuse potential of tramadol in humans
KE Dunn, CL Bergeria, AS Huhn, EC Strain
Frontiers in Psychiatry 10, 704, 2019
412019
Opioid Overdose Education for Individuals Prescribed Opioids for Pain Management: Randomized Comparison of Two Computer-Based Interventions
AS Huhn, AP Garcia-Romeu, KE Dunn
Frontiers in Psychiatry 9, 34, 2018
392018
Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes
KE Dunn, EM Weerts, AS Huhn, JR Schroeder, DA Tompkins, GE Bigelow, ...
Addiction biology 25 (1), e12680, 2020
372020
Sleep disturbance as a therapeutic target to improve opioid use disorder treatment.
AS Huhn, PH Finan
Experimental and clinical psychopharmacology, 2021
292021
The system can't perform the operation now. Try again later.
Articles 1–20